COVID-19 pandemic
Moderna begins testing its vaccine in babies and children aged six months to 11 years in the U.S. and Canada.
Sources: The Wall Street Journal
Changes
- Moderna begins studying its vaccine in baby and children aged six months to 11 years in the U.S. and Canada in collaboration with the National Institute of Allergy and Infectious Diseases and a division of the Department of Health and Human Services, which the first children have received the vaccine.
- Moderna begins studying its vaccine in babies and children aged six months to 11 years in the U.S. and Canada.
- Moderna begins testing its vaccine in babies and children aged six months to 11 years in the U.S. and Canada.